Apricus Biosciences, Inc.
(NASDAQ : APRI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading APRI News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-1.06%10.759.9%$297.33m
PRGOPerrigo Co. Plc
-0.29%67.964.8%$179.65m
SHPGShire PLC Sponsored ADR
0.70%175.230.3%$161.46m
MDCOMedicines Company
1.40%50.6922.6%$134.46m
ENDPEndo International Plc
-0.20%9.978.9%$131.03m
JAZZJazz Pharmaceuticals Plc
0.45%143.141.9%$89.29m
MNKMallinckrodt Plc
-0.21%43.0912.8%$86.79m
UTHRUnited Therapeutics Corporation
0.66%140.0511.5%$85.74m
PRXLPAREXEL International Corporation
0.86%62.356.7%$70.21m
PCRXPacira Pharmaceuticals, Inc.
-0.11%46.9016.9%$67.17m
PTLAPortola Pharmaceuticals, Inc.
0.55%38.4410.3%$48.48m
ICPTIntercept Pharmaceuticals, Inc.
0.80%116.7322.8%$45.29m
HZNPHorizon Pharma plc
-1.31%14.379.7%$45.07m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.04%121.179.9%$39.39m
ICLRICON Plc
1.73%78.942.8%$38.72m

Company Profile

Apricus Biosciences, Inc. is a pharmaceutical company focus on the development and commercialization of products and product candidates in the areas of specialty urology and rheumatology. The company products include Vitaros and Femprox. It operates through Pharmaceutical segment which designs and develops pharmaceutical products including those with its NexACT platform. Apricus Biosciences was founded in 1987 and is headquartered in San Diego, CA.